Skip to main content
Fig. 2 | BMC Neuroscience

Fig. 2

From: Assessing the protective effect of rosiglitazone against electronic cigarette/tobacco smoke-induced blood–brain barrier impairment

Fig. 2

RSG decreases intracellular ROS generation and inflammation by TC/EC. a Intracellular ROS generation measured by flow cytometry. b Expression level of the inflammatory marker PECAM-1 which was increased in cells treated with TS/EC was downregulated by RSG. n = 3 to 4 biological replicates; *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001, versus control; +++p < 0.001, ++++p < 0.0001, TS/EC versus TS/EC + RSG

Back to article page